MetaADEDB 2.0 @ LMMD
Dichlorphenamide
(GJQPMPFPNINLKP-UHFFFAOYSA-N)
Structure
SMILES
Clc1cc(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N
Type(s)
Approved; Investigational
ATC code(s)
G01AE10; S01EC02
Molecular Formula:
C6H6Cl2N2O4S2
Molecular Weight:
305.159
Log P:
3.8504
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
137.08
CAS Number(s):
120-97-8
Synonym(s)
1.
Dichlorphenamide
2.
Diclofenamid
3.
Daranide
4.
Dichlofenamide
5.
Glauconide
External Link(s)
MeSHD004005
PubChem Compound3038
BindingDB10883
ChEBI101085
CHEMBLCHEMBL17
DrugBankDB01144
DrugCentral864
IUPHAR/BPS Guide to PHARMACOLOGY6807
KEGGcpd:C07459
dr:D00518
Therapeutic Target DatabaseD0R0QE
D0J4GO
ZINC896918
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 81SIDER
US FAERS
2Disease recurrenceFAERS: 79US FAERS
3Feeling abnormalFAERS: 53SIDER
US FAERS
4DizzinessFAERS: 45SIDER
US FAERS
5NauseaFAERS: 45
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6DysgeusiaFAERS: 42US FAERS
7Intentional product use issueFAERS: 31US FAERS
8MalaiseFAERS: 30US FAERS
9AstheniaFAERS: 28SIDER
US FAERS
10Drug dose omissionFAERS: 27US FAERS
11HeadacheFAERS: 27SIDER
US FAERS
12Weight decreasedFAERS: 26SIDER
US FAERS
13Blood potassium decreasedFAERS: 24US FAERS
14Memory impairmentFAERS: 22US FAERS
15Abdominal discomfortFAERS: 20US FAERS
16NasopharyngitisFAERS: 20US FAERS
17Drug ineffectiveFAERS: 19US FAERS
18InfluenzaFAERS: 19US FAERS
19MyalgiaFAERS: 16US FAERS
20Prescribed underdoseFAERS: 15US FAERS
21ArthralgiaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
22AphasiaFAERS: 13US FAERS
23SomnolenceFAERS: 13SIDER
US FAERS
24Intentional dose omissionFAERS: 12US FAERS
25NephrolithiasisFAERS: 12SIDER
US FAERS
26PainFAERS: 12US FAERS
27Drug effect incompleteFAERS: 11US FAERS
28Product dose omissionFAERS: 10US FAERS
29PruritusFAERS: 10SIDER
US FAERS
30AmnesiaFAERS: 8US FAERS
31Intentional product misuseFAERS: 8US FAERS
32PolyuriaFAERS: 8US FAERS
33SinusitisFAERS: 8US FAERS
34Visual ImpairmentFAERS: 8US FAERS
35AnxietyFAERS: 7US FAERS
36DyspepsiaFAERS: 7SIDER
US FAERS
37PalpitationsFAERS: 7US FAERS
38Therapeutic response unexpectedFAERS: 7US FAERS
39VomitingFAERS: 7SIDER
US FAERS
40Abdominal PainFAERS: 6US FAERS
41Back PainFAERS: 6US FAERS
42DehydrationFAERS: 6US FAERS
43Drug administered to patient of inappropriate ageFAERS: 6US FAERS
44Mental impairmentFAERS: 6US FAERS
45TinnitusFAERS: 6SIDER
US FAERS
46BronchitisFAERS: 5US FAERS
47Depressed moodFAERS: 5US FAERS
48DiplopiaFAERS: 5US FAERS
49Feeling ColdFAERS: 5US FAERS
50HungerFAERS: 5US FAERS
51Musculoskeletal stiffnessFAERS: 5US FAERS
52PneumoniaFAERS: 5US FAERS
53Wrong technique in product usage processFAERS: 5US FAERS
54Blood potassium increasedFAERS: 4US FAERS
55Chest discomfortFAERS: 4US FAERS
56ChillsFAERS: 4US FAERS
57DisorientationFAERS: 4SIDER
US FAERS
58HypersomniaFAERS: 4US FAERS
59LethargyFAERS: 4US FAERS
60LymphadenopathyFAERS: 4US FAERS
61Metabolic acidosisFAERS: 4SIDER
US FAERS
62Musculoskeletal PainFAERS: 4US FAERS
63SyncopeFAERS: 4US FAERS
64Tooth InfectionFAERS: 4US FAERS
65TremorFAERS: 4SIDER
US FAERS
66AcidosisFAERS: 3US FAERS
67Adverse eventFAERS: 3US FAERS
68AsthenopiaFAERS: 3US FAERS
69Blood glucose increasedFAERS: 3US FAERS
70Burning sensationFAERS: 3US FAERS
71Chest PainFAERS: 3US FAERS
72ChromaturiaFAERS: 3US FAERS
73ConstipationFAERS: 3SIDER
US FAERS
74Disease ProgressionFAERS: 3US FAERS
75ErythemaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Eye painFAERS: 3US FAERS
77Head discomfortFAERS: 3US FAERS
78HypersensitivityFAERS: 3US FAERS
79HypogeusiaFAERS: 3US FAERS
80HypokinesiaFAERS: 3US FAERS
81HypotensionFAERS: 3US FAERS
82Inappropriate schedule of drug administrationFAERS: 3US FAERS
83Limb discomfortFAERS: 3US FAERS
84NocturiaFAERS: 3US FAERS
85Oral candidiasisFAERS: 3US FAERS
86Product use issueFAERS: 3US FAERS
87Renal painFAERS: 3US FAERS
88SunburnFAERS: 3US FAERS
89ThirstFAERS: 3US FAERS
90Urinary tract infectionFAERS: 3US FAERS
91VertigoFAERS: 3US FAERS
92Atrial FibrillationFAERS: 2US FAERS
93Blood iron decreasedFAERS: 2US FAERS
94Blood pH decreasedFAERS: 2US FAERS
95Blood phosphorus decreasedFAERS: 2US FAERS
96BradycardiaFAERS: 2US FAERS
97Drug effect variableFAERS: 2US FAERS
98Drug ineffective for unapproved indicationFAERS: 2US FAERS
99DysarthriaFAERS: 2US FAERS
100DysmetropsiaFAERS: 2US FAERS
101Ear discomfortFAERS: 2US FAERS
102EpistaxisFAERS: 2US FAERS
103EructationFAERS: 2US FAERS
104GoutFAERS: 2US FAERS
105InfectionFAERS: 2US FAERS
106Initial insomniaFAERS: 2US FAERS
107Loss of personal independence in daily activitiesFAERS: 2US FAERS
108Medication ErrorFAERS: 2US FAERS
109Musculoskeletal discomfortFAERS: 2US FAERS
110MyopathyFAERS: 2US FAERS
111NervousnessFAERS: 2SIDER
US FAERS
112Oropharyngeal painFAERS: 2US FAERS
113ParanoiaFAERS: 2US FAERS
114Peripheral swellingFAERS: 2US FAERS
115PolydipsiaFAERS: 2US FAERS
116RestlessnessFAERS: 2US FAERS
117Secretion dischargeFAERS: 2US FAERS
118Sexual DysfunctionFAERS: 2US FAERS
119Skin irritationFAERS: 2US FAERS
120SluggishnessFAERS: 2US FAERS
121Stevens-Johnson SyndromeFAERS: 2US FAERS
122Stress at workFAERS: 2US FAERS
123Symptom recurrenceFAERS: 2US FAERS
124Throat irritationFAERS: 2US FAERS
125TrismusFAERS: 2US FAERS
126Unevaluable eventFAERS: 2US FAERS
127UrticariaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
128furuncleFAERS: 2US FAERS
129AbasiaFAERS: 1US FAERS
130Abnormal sleep-related eventFAERS: 1US FAERS
131Acute kidney injuryFAERS: 1US FAERS
132Allergic reaction to excipientFAERS: 1US FAERS
133AlopeciaFAERS: 1US FAERS
134Anorectal discomfortFAERS: 1US FAERS
135ApathyFAERS: 1US FAERS
136AtaxiaFAERS: 1SIDER
US FAERS
137Back disorderFAERS: 1US FAERS
138Blood creatinine decreasedFAERS: 1US FAERS
139Blood magnesium increasedFAERS: 1US FAERS
140Blood potassium abnormalFAERS: 1US FAERS
141Blood sodium decreasedFAERS: 1US FAERS
142Bone painFAERS: 1US FAERS
143Carbon dioxide decreasedFAERS: 1US FAERS
144Cataract operationFAERS: 1US FAERS
145CellulitisFAERS: 1US FAERS
146Cerebral disorderFAERS: 1US FAERS
147ChemotherapyFAERS: 1US FAERS
148ColitisFAERS: 1US FAERS
149CryingFAERS: 1US FAERS
150CystFAERS: 1US FAERS
151DiplegiaFAERS: 1US FAERS
152Discontinued product administeredFAERS: 1US FAERS
153DiverticulitisFAERS: 1US FAERS
154DroolingFAERS: 1US FAERS
155Drug prescribing errorFAERS: 1US FAERS
156Dry skinFAERS: 1US FAERS
157Electrolyte imbalanceFAERS: 1SIDER
US FAERS
158Emotional distressFAERS: 1US FAERS
159EpicondylitisFAERS: 1US FAERS
160Erectile dysfunctionFAERS: 1US FAERS
161ExophthalmosFAERS: 1US FAERS
162Extra dose administeredFAERS: 1US FAERS
163Eye irritationFAERS: 1US FAERS
164Facial PainFAERS: 1US FAERS
165Feeling jitteryFAERS: 1US FAERS
166FibromyalgiaFAERS: 1US FAERS
167Flat affectFAERS: 1US FAERS
168Food PoisoningFAERS: 1US FAERS
169Gastric BypassFAERS: 1US FAERS
170Gastric ulcerFAERS: 1US FAERS
171GastroenteritisFAERS: 1US FAERS
172Gastrointestinal viral infectionFAERS: 1US FAERS
173GlaucomaFAERS: 1US FAERS
174Hypertensive crisisFAERS: 1US FAERS
175HypothyroidismFAERS: 1US FAERS
176Impaired driving abilityFAERS: 1US FAERS
177Impaired work abilityFAERS: 1US FAERS
178Inappropriate schedule of product administrationFAERS: 1US FAERS
179IncoherentFAERS: 1US FAERS
180Irritable Bowel SyndromeFAERS: 1US FAERS
181Joint injuryFAERS: 1US FAERS
182Joint stiffnessFAERS: 1US FAERS
183Joint swellingFAERS: 1US FAERS
184LaryngitisFAERS: 1US FAERS
185Limb injuryFAERS: 1US FAERS
186Lip swellingFAERS: 1US FAERS
187Lower respiratory tract congestionFAERS: 1US FAERS
188Lyme DiseaseFAERS: 1US FAERS
189MastectomyFAERS: 1US FAERS
190Mouth swellingFAERS: 1US FAERS
191Muscle FatigueFAERS: 1US FAERS
192Muscle RigidityFAERS: 1US FAERS
193Muscle tightnessFAERS: 1US FAERS
194Myocardial InfarctionFAERS: 1US FAERS
195MyotoniaFAERS: 1US FAERS
196Nerve injuryFAERS: 1US FAERS
197NeuralgiaFAERS: 1US FAERS
198OsteopeniaFAERS: 1US FAERS
199PeriarthritisFAERS: 1US FAERS
200PhotophobiaFAERS: 1US FAERS
201Poor quality sleepFAERS: 1US FAERS
202Postural Orthostatic Tachycardia SyndromeFAERS: 1US FAERS
203PregnancyFAERS: 1US FAERS
204Prescription drug used without a prescriptionFAERS: 1US FAERS
205Product prescribing issueFAERS: 1US FAERS
206Product substitution issueFAERS: 1US FAERS
207Productive CoughFAERS: 1US FAERS
208Pulmonary EmbolismFAERS: 1US FAERS
209Restless Legs SyndromeFAERS: 1US FAERS
210Rotator cuff syndromeFAERS: 1US FAERS
211Salt cravingFAERS: 1US FAERS
212SciaticaFAERS: 1US FAERS
213Spinal StenosisFAERS: 1US FAERS
214StressFAERS: 1US FAERS
215SwellingFAERS: 1US FAERS
216TachycardiaFAERS: 1US FAERS
217Temperature intoleranceFAERS: 1US FAERS
218Therapeutic product effect incompleteFAERS: 1US FAERS
219Therapy changeFAERS: 1US FAERS
220Tongue discomfortFAERS: 1US FAERS
221Tongue pigmentationFAERS: 1US FAERS
222Urinary IncontinenceFAERS: 1US FAERS
223Urinary RetentionFAERS: 1US FAERS
224Vein collapseFAERS: 1US FAERS
225Vitamin D DeficiencyFAERS: 1US FAERS
226Vocal Cord ParalysisFAERS: 1US FAERS
227Wheelchair userFAERS: 1US FAERS
228muscle injuryFAERS: 1US FAERS
229AgranulocytosisSIDER
230AnorexiaSIDER
231Conversion disorderSIDER
232DiscomfortCanada Vigilance: 1Canada Vigilance
233DrowsinessSIDER
234Hepatic InsufficiencySIDER
235LassitudeSIDER
236LeukopeniaSIDER
237PallorCanada Vigilance: 1Canada Vigilance
238Rash erythematousCanada Vigilance: 1Canada Vigilance
239Renal ColicSIDER
240TensionSIDER
241ThrombocytopeniaSIDER
242Urine phosphorus increasedSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.